Lytix Biopharma AS (OSL: LYTIX)

Lytix Biopharma AS Revenue

Lytix Biopharma AS had revenue of 231.00K NOK in the quarter ending September 30, 2024, a decrease of -94.10%. This brings the company's revenue in the last twelve months to 10.76M, down -20.98% year-over-year. In the year 2023, Lytix Biopharma AS had annual revenue of 3.99M, down -63.82%.

• Revenue (ttm): 10.76M
• Revenue Growth: -20.98%
• P/S Ratio: n/a
• Revenue / Employee: 1.34M
• Employees: 8
• Market Cap: 287.74M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	3.99M	-7.04M	-63.82%
Dec 31, 2022	11.03M	-8.28M	-42.87%
Dec 31, 2021	19.31M	15.23M	373.91%
Dec 31, 2020	4.07M	-2.27M	-35.73%
Dec 31, 2019	6.34M	-5.48M	-46.38%